Dianthus Therapeutics | Eiendeler



Assets Endring Dato
Adcock Ingram Holdings ZAR 8.35B 25.86M 2024-06
Alaunos Therapeutics USD 3.55M 1.13M 2024-09
Avita Medical AUD 79.71M 8.12M 2024-12
Celltrion KRW 20.31T 180.03B 2024-09
Cspc Pharmaceutical CNY 44.39B 3.51B 2024-12
Dianthus Therapeutics USD 374.01M 19.76M 2024-12
Ecofibre AUD 71.25M 1.95M 2024-06
IQVIA Holdings USD 26.9B 281M 2024-12
Kangmei Pharma CNY 14.19B 63.4M 2024-09
Knight Therapeutics CAD 962.29M 16.93M 2024-09
Laboratorios Farma EUR 832.02M 25.3M 2024-12
Malin Corporation EUR 128.4M 11.8M 2024-06
Medical Developments International AUD 59.16M 31.9M 2024-06
Moderna USD 14.14B 1.66B 2024-12
Neuren Pharmaceuticals AUD 409.71M 181.55M 2024-12
Organigram Holdings CAD 479.21M 71.35M 2024-12
Organon & Co USD 13.1B 349M 2024-12
Pharma Mar EUR 349.64M 16.52M 2024-12
Qiagen NV USD 5.69B 580.57M 2024-12
Revvity USD 12.39B 377.26M 2024-12
Sartorius EUR 9.79B 148.6M 2024-09
Sino Biopharmaceutical CNY 65.41B 1.3B 2024-12
Tectonic Therapeutic USD 152.9M 15.81M 2024-12
Tilray USD 4.19B 70.11M 2024-11
Viatris USD 41.5B 3.25B 2024-12
Xeris Pharmaceuticals USD 323.06M 1.96M 2024-12
Zz Pientze Pharmaceu 17.99B 940.45M 2024-09



Dianthus Therapeutics Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.